U.S. Machinery Stock News

NYSE:BYD
NYSE:BYDHospitality

Is Boyd Gaming (BYD) Cheap As Lower Earnings Cloud Its Latest Results?

Boyd Gaming (BYD) has drawn investor attention after releasing its second quarter and half year 2026 results, which showed steady revenue along with lower net income and slightly softer earnings per share. See our latest analysis for Boyd Gaming. Boyd Gaming's latest earnings update has coincided with softer trading, with the share price at US$84.32 and a 7 day share price return that fell 7.13%. In contrast, the 1 year total shareholder return of 2.14% and 5 year total shareholder return of...
NYSE:HPP
NYSE:HPPOffice REITs

Hudson Pacific Properties (HPP) Stock Rallies On Core FFO Rebound Despite Wider Losses

Hudson Pacific Properties stock jumped 7.1% to US$14.97 after the Q2 release, a sharp move for a company that came into today with a flat week and a tough recent track record. The headline was not earnings per share. The market latched on to a different story. Core funds from operations, or core FFO, nearly tripled to US$23.1 million and management nudged full year core FFO guidance higher. The short term price pop is about relief and renewed confidence. The bigger question for you is whether...
NasdaqGS:ASTS
NasdaqGS:ASTSTelecom

AST SpaceMobile (ASTS) Stock Looks Expensive Next To Its Assets

AST SpaceMobile stock has delivered extremely strong multi year returns, yet the current valuation checks and recent share price swings suggest the market may now be paying up for that story rather than offering clear value. AST SpaceMobile has returned roughly 14x over the past 3 years. This puts extra pressure on today’s investors to judge whether expectations have run ahead of fundamentals. Progress on its space based cellular network, including recent BlueBird satellite launches and...
NasdaqGS:RARE
NasdaqGS:RAREBiotechs

Ultragenyx (RARE) Stock Revenue Record Clashes With Ongoing Cash Burn

Ultragenyx Pharmaceutical stock slipped 3.4% to about US$24.93 as investors digested a fresh set of numbers that mixed record sales with continued losses. Q2 revenue reached US$214m, led by rare disease drugs such as Crysvita, while the company still reported a net loss of US$92m, or US$0.90 per share. For traders focused on this week, that loss keeps the pressure on. For investors thinking in years rather than days, the key points are the record top line, the active late stage pipeline and...
NYSE:JLL
NYSE:JLLReal Estate

Jones Lang LaSalle (JLL) Is Up 9.8% After Strong Q2, Reaffirmed 2026 Outlook And Buybacks

In the second quarter of 2026, Jones Lang LaSalle reported higher sales of US$6,927.9 million and net income of US$215.6 million year over year, affirmed its mid- to high single-digit revenue growth target for 2026, and completed a multiyear buyback totaling 8,106,124 shares for US$1.82 billion. Together, the stronger earnings, reaffirmed growth outlook, and sizeable share repurchases highlight management’s confidence in the business and the company’s focus on enhancing per-share...
NasdaqGS:GH
NasdaqGS:GHHealthcare

Guardant Health (GH) Stock May Be Below Fair Value After Raised Guidance

Guardant Health stock has delivered very strong returns over the past few years, yet the signals on what that means for valuation are mixed, with the Discounted Cash Flow (DCF) intrinsic value estimate pointing to upside while market multiples suggest the shares screen expensive. Guardant Health has returned 347.6% over the past three years, which puts extra focus on whether the current share price leaves much margin for error. Growing adoption of the Guardant360 and Shield blood tests may...
NYSE:DECK
NYSE:DECKLuxury

Raised 2027 EPS Guidance and Major Buybacks Might Change The Case For Investing In Deckers Outdoor (DECK)

Deckers Outdoor recently reported first-quarter 2026 results, showing sales of US$1,019.53 million and net income of US$129.97 million, while also updating full-year 2027 guidance to higher expected revenue, slightly better than 21.5% operating margin, and diluted EPS of US$7.35–US$7.50 supported by ongoing share repurchases. The company’s decision to tie its raised earnings outlook to repurchasing shares worth roughly 80% of projected fiscal 2027 free cash flow underlines how capital...
NasdaqGS:FRPH
NasdaqGS:FRPHReal Estate

FRP Holdings (FRPH) Stock Revenue Growth Clashes With Vanishing Margins

FRP Holdings stock slipped 2.4% to US$21.93 after its Q2 report, yet the real story sits in a different place than the share chart. The headline this quarter is a squeeze on profitability. Trailing net profit margin has compressed to 0.3% compared with 16.5% a year earlier, and reported earnings over the past five years have retreated at an average rate of 45.8% a year. Investors are reacting to that margin picture more than to the solid real estate platform or cash on hand. The question now...
NasdaqGS:MQ
NasdaqGS:MQDiversified Financial

Marqeta (MQ) Stock Falls As Profit Gains Meet Slower Growth Outlook

Marqeta stock just handed investors a 7% one day drop, yet the earnings story leans far more toward a profitability grind than a collapse. Coming into the print, the stock had been roughly flat over three months, with only a small gain over 30 days. Then the market met a payments platform that printed about US$176m in Q2 net revenue and roughly US$8m in net income, its second straight profitable quarter. The real headline is margin power. Adjusted earnings before interest, tax, depreciation...
NYSE:PAG
NYSE:PAGSpecialty Retail

How Softer EPS Amid Rising Sales Will Impact Penske Automotive Group (PAG) Investors

Penske Automotive Group recently reported past second-quarter 2026 results, with sales rising to US$8,297.2 million while net income eased to US$260.4 million and basic earnings per share from continuing operations slipped to US$3.96. Over the same period, the company also continued its long-running repurchase program, buying 94,711 shares for US$16.1 million and bringing total buybacks under the 2010 authorization to 31.05 million shares, or 38.85% of its shares at launch. We’ll now examine...
NYSE:BX
NYSE:BXCapital Markets

Blackstone (BX) Earnings And Dividend Lift Put Valuation Back In Focus

Blackstone (BX) is in focus after reporting second quarter results on July 23, 2026, that showed higher revenue and net income compared with a year earlier, alongside a larger quarterly dividend for shareholders. See our latest analysis for Blackstone. At a share price of $136.03, Blackstone has seen a 7 day share price return of 5.12% and a 30 day share price return of 10.22%. Year to date the share price return is down 14.34%, while the 3 year total shareholder return of 49.50% points to a...
NYSE:LPX
NYSE:LPXBuilding

Louisiana Pacific (LPX) Stock Can Siding Strength Justify A 100x P E

Louisiana-Pacific stock barely budged after earnings, up just 0.7% to US$77.36, yet the quarter itself was anything but quiet. The company posted Q2 2026 revenue of US$664m and basic earnings per share of US$0.37, with investors weighing those construction cycle exposed numbers against a rich trailing P/E of about 100x. The real story for you is the squeeze between modest profits and a high multiple, especially with trailing net profit margin running at 2.2% and a recent one off loss still...
NYSE:ZETA
NYSE:ZETASoftware

Zeta Global (ZETA) Stock Jumps As Profitability Arrives With AI Fueled Growth

Zeta Global Holdings went into this earnings print as a high growth marketing and AI platform stock with a loyal bull camp and a lot to prove on profitability. The market liked what it saw. The share price jumped 11.6% to US$27.07 after the release, extending a strong three month run. The headline this quarter is profit. Zeta Global Holdings shifted from a loss in Q1 to GAAP net income of US$8.2 million, with basic earnings per share of US$0.03, on revenue of US$442.8 million. That move into...
NasdaqGS:MRNA
NasdaqGS:MRNABiotechs

Moderna (MRNA) Begins First Phase 1 Trial For Bundibugyo Ebola Vaccine

Moderna (NasdaqGS:MRNA) has started the first Phase 1 clinical trial of an mRNA vaccine targeting the Bundibugyo strain of the Ebola virus. The trial follows authorization from Health Canada and is conducted in partnership with the Coalition for Epidemic Preparedness Innovations, or CEPI. Moderna and CEPI have pledged to support access to the Bundibugyo ebolavirus vaccine for low and middle income countries if it is approved. For investors watching how Moderna's mRNA platform extends beyond...
NYSE:DOC
NYSE:DOCHealth Care REITs

Healthpeak Properties (DOC) Stock Finds Support In Stronger FFO

Healthpeak Properties stock barely budged, up less than 1% to around US$21.79, even though the earnings story was all about stronger cash generation. For a real estate investment trust, funds from operations is what matters, and Healthpeak reported adjusted funds from operations of US$0.46 per share in the quarter with total revenue of US$771.6m. The market reaction looks muted compared with that core cash figure and a raised full year adjusted funds from operations guidance range. Investors...
NYSE:BANC
NYSE:BANCBanks

The Bull Case For Banc of California (BANC) Could Change Following Q2 Loss And Surge In Charge-Offs

Banc of California, Inc. reported second-quarter 2026 results showing net interest income of US$250.5 million but a net loss of US$241.35 million, a reversal from net income a year earlier, alongside basic and diluted losses per share of US$1.61 from continuing operations. The quarter also saw net charge-offs surge to US$160,281,000 from US$44,222,000 a year ago, highlighting a sharp deterioration in credit costs even as management emphasized balance sheet repositioning efforts. We’ll now...
NYSE:LW
NYSE:LWFood

Lamb Weston Holdings (LW) Reports Mixed Results And Cautious Guidance, Is The Stock Above Fair Value?

What the latest Lamb Weston guidance tells you Lamb Weston Holdings (LW) has just paired mixed fourth quarter and full year earnings with cautious fiscal 2027 guidance, flagging expected net sales growth of 0.0% to 1.0% alongside softer profitability measures. For you as an investor, that combination of modest sales expectations, declining net income and earnings per share, and commentary on waning demand presents questions about how the stock reflects slower organic growth and international...
NasdaqGS:AEP
NasdaqGS:AEPElectric Utilities

How Investors Are Reacting To American Electric Power (AEP) Revenue Growth With Softer Earnings And New EPS Guidance

American Electric Power Company, Inc. has already reported its second-quarter 2026 results, with sales rising to US$5,311 million and revenue to US$5,445 million, while net income declined to US$713 million and diluted EPS from continuing operations eased to US$1.30. For the first half of 2026, the company paired higher revenue of US$11,465 million with lower net income of US$1,587 million and issued full-year GAAP EPS guidance of US$6.16 to US$6.46, highlighting a shift toward top-line...
NasdaqCM:NAGE
NasdaqCM:NAGEPersonal Products

Niagen Bioscience (NAGE) Stock Sinks As Profit Cushion Thins

Niagen Bioscience stock just absorbed a sharp reality check, closing at US$2.96, which is a 14.7% slide from the prior session. That kind of move grabs attention, yet the Q2 print itself was more muted than the chart suggests. Revenue landed at US$29.8m and net income was about US$1m, keeping the company in the black but at a much slimmer level than earlier quarters. For investors with a longer lens, the headline is not the single quarter. It is how this thinner profitability sits against...
NasdaqGS:HBAN
NasdaqGS:HBANBanks

Higher Rates Are Reviving Interest In These 3 Regional Bank Stocks

Higher-for-longer interest rate talk is back, with Minneapolis Fed President Neel Kashkari and other policymakers floating fresh hikes while inflation readings such as CPI at 3.5% and PCE at 3.7% keep pressure on cash. That puts short-duration fixed income and cash equivalent stocks in the spotlight as investors reassess where to park money. This article profiles 3 stocks that screen well against this rate shock story. The three stocks highlighted below are just a starting sample, with the...
NYSE:IT
NYSE:ITIT

Gartner (IT) Is Up 12.5% After Raising 2026 Guidance And Accelerating Share Buybacks - What's Changed

In early August 2026, Gartner reported second-quarter results showing revenue of US$1,675.94 million, net income of US$275.5 million, and diluted EPS of US$4.14 from continuing operations, while updating 2026 guidance to target at least US$6.38 billion in FX-neutral revenue. Gartner also intensified capital returns by repurchasing 3,600,000 shares for US$547 million in the quarter, bringing cumulative buybacks under its long-running program to 32,840,858 shares for US$7.39 billion, which...
NasdaqGS:ROCK
NasdaqGS:ROCKBuilding

Gibraltar Industries (ROCK) Stock Reprices As OmniMax Lifts Revenue And Leverage Looms

The market just put Gibraltar Industries on a pedestal. The stock jumped 14.2% to US$54.86 the first trading day after earnings, after already strong gains over the past quarter. That kind of one day repricing only happens when investors decide the story has changed. The headline this time is clear. Q2 revenue reached about US$509.5m with the first full quarter of OmniMax in the fold and adjusted earnings per share landed solidly in profitable territory after a weak Q1. The real question for...
NasdaqGS:HLNE
NasdaqGS:HLNECapital Markets

Hamilton Lane (HLNE) Earnings Beat And Higher Dividend Put Fair Value Back In Focus

Hamilton Lane (HLNE) stock drew fresh attention after the company reported earnings and revenue above market estimates, and it also announced an 11% higher full year dividend target of US$2.40 per share. See our latest analysis for Hamilton Lane. Despite the strong quarter and higher dividend guidance, Hamilton Lane’s recent news has played out against a mixed price backdrop, with the share price up 25.1% over the last month yet down 26.2% year to date and the 1 year total shareholder return...
NYSE:SBH
NYSE:SBHSpecialty Retail

How Sally Beauty’s Lowered 2026 Sales Outlook and COLORfest Pivot Could Shape SBH’s Investment Case

Sally Beauty Holdings reported past third-quarter 2026 results showing sales of US$935.49 million and higher year-on-year earnings, while also trimming its full-year Fiscal 2026 consolidated net sales guidance to a range of US$3.73 billion to US$3.73 billion. At the same time, the company is pushing COLORfest and COLORfest on Campus and broadening into skin and body care, highlighting a focus on younger consumers and higher-margin categories despite its more cautious sales outlook. We’ll now...